A
AxioMed Spine
AxioMed Spine develops products that restore the spinal function of patients with degenerative spine diseases
About AxioMed Spine
Axiomed is a pioneering company in the medical device industry, specializing in next-generation total disc replacement solutions. The company focuses on developing innovative, one-piece disc replacement devices designed to provide both flexibility and support, thereby facilitating pain relief and the restoration of normal spinal function for patients suffering from degenerative disc disease. Axiomed serves a diverse range of clients, including healthcare providers, hospitals, and clinics that treat spinal conditions. Operating in the global medical device market, Axiomed's business model revolves around the research, development, and commercialization of advanced spinal care technologies. The company generates revenue through the sale of its proprietary disc replacement devices and related services. By leveraging cutting-edge technology and a patient-centric approach, Axiomed aims to redefine patient outcomes and improve the quality of life for individuals with spinal disorders.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2022 | $12M | $48M | Undisclosed | ↗ |
| DEBTDebt | Jan 2017 | $1M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for AxioMed Spine is 500 monthly website visits, down 15.3% over the last three months. AxioMed Spine's team grew 15.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
AxioMed Spine in the Fort Lauderdale ecosystem
The AxioMed Spine office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- RPReservoir Venture Partners
- EPEarly Stage Partners
- CPCID Equity Partners
Thomas McNerney & Partners
Primus Venture Partners
MB Venture Partners
Series B and later2 investors entered at this stage
Primus Capital Partners
Investor Growth Capital
Other known investors1 additional known investor
Cleveland Clinic Lerner College of Medicine
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AxioMed Spine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AxioMed Spine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








